Evidence map›Paper›PMID 37206915›Full record

ArticleFrontiers in toxicology2023

Substantiate a read-across hypothesis by using transcriptome data-A case study on volatile diketones.

Christina Drake, Matthias M Wehr, Walter Zobl, Jeannette Koschmann, David De Lucca, Britta A Kühne, Tanja Hansen, Jan Knebel, Detlef Ritter, Jan Boei and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. New approach methodologies (NAMs) for theFrontiers in toxicology · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Christina DrakeFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Matthias M WehrFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Walter ZoblFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Jeannette KoschmannGeneXplain GmbH, Wolfenbüttel, Germany.
David De LuccaMedizinische Hochschule Hannover, Hannover, Germany.
Britta A KühneFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Tanja HansenFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Jan KnebelFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Detlef RitterFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Jan BoeiLeiden University Medical Center, Leiden, Netherlands.
Harry VrielingLeiden University Medical Center, Leiden, Netherlands.
Annette BitschFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Sylvia E EscherFraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Hannover, Germany.
Fraunhofer Institute for Toxicology and Experimental Medicine · DELeiden University Medical Center · NLGeneXplain (Germany) · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case study explores the applicability of transcriptome data to characterize a common mechanism of action within groups of short-chain aliphatic α-, β-, and γ-diketones. Human reference

Indexed as

new approach methodologyPBECprotein network analysisread acrossTempO-seqtranscriptomics

Identifiers

PMID37206915
PMCPMC10188990
OpenAlexW4368375593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.